{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,4]],"date-time":"2026-04-04T16:35:47Z","timestamp":1775320547695,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T00:00:00Z","timestamp":1747094400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["834974"],"award-info":[{"award-number":["834974"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["834974"],"award-info":[{"award-number":["834974"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["834974"],"award-info":[{"award-number":["834974"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["834974"],"award-info":[{"award-number":["834974"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["834974"],"award-info":[{"award-number":["834974"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","award":["834974"],"award-info":[{"award-number":["834974"]}],"id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Universit\u00e4tsklinikum Hamburg-Eppendorf (UKE)"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Exp Clin Cancer Res"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Background<\/jats:title>\n            <jats:p>The potential influence of radical prostatectomy on tumor cell release into the blood circulation is an under-investigated area.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>One hundred three treatment-na\u00efve patients with early-stage prostate cancer were recruited. Blood from the prostatic venous plexus was analyzed for the local release of tumor cells during radical prostatectomy. Simultaneously, systemic spread was assessed by the presence of circulating tumor cells (CTCs) in peripheral venous blood using both the EpCAM-dependent CellSearch and the size-dependent Parsortix systems in parallel. Tumor cells in the plexus blood and CTCs were detected by epithelial keratin expression and lack of CD45 leukocyte antigen.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Median counts of Keratin\u2009+\u2009\/CD45- cells detected in peripheral blood with the CellSearch and Parsortix systems differed significantly (<jats:italic>p\u2009=<\/jats:italic>\u20090.0067) with higher sensitivity of the Parsortix System (16 vs 32% positive findings). Even if the results of both assays were combined, the median number of Keratin\u2009+\u2009\/CD45- cells in the prostatic plexus blood was significantly higher than in the peripheral blood (97 vs. 2 per 7.5 ml, respectively, <jats:italic>p<\/jats:italic>\u2009&lt;\u20090.0001). Keratin\u2009+\u2009\/CD45- cells could be identified in 85% of prostate cancer patients in the prostatic plexus blood and in 42% of patients in peripheral blood during surgery without any significant correlation. Keratin\u2009+\u2009\/CD45- cell clusters were identified in the prostatic plexus in 51.2% of patients but neither these clusters nor single Keratin\u2009+\u2009\/CD45- cells were associated with biochemical relapse during follow-up. The presence (<jats:italic>p\u2009=<\/jats:italic>\u20090.0094) and number (<jats:italic>p\u2009=<\/jats:italic>\u20090.0153) of CTCs in the peripheral blood was significantly associated with PSA levels at initial diagnosis. Single-cell genome-wide sequencing by NGS showed copy number alterations (CNAs) in 15 out of 26 index CTCs originating from both the prostatic plexus and peripheral blood compartments.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>Combining different CTC enrichment principles increases the CTC detection rate in the peripheral blood of early-stage prostate cancer patients. Our study provides first evidence for a considerable local release of normal and malignant epithelial cells during prostatectomy, which, however, was neither associated with increased CTC detection in the peripheral blood nor with early biochemical recurrence. Longer follow up studies are required to assess whether local tumor cell spread might contribute to clinical outcome in prostate cancer.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1186\/s13046-025-03397-5","type":"journal-article","created":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T07:37:47Z","timestamp":1747121867000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Comparative analysis of circulating tumor cells in prostatic plexus and peripheral blood of patients undergoing prostatectomy"],"prefix":"10.1186","volume":"44","author":[{"given":"Gresa","family":"Emurlai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randi M.","family":"Pose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cornelia","family":"Coith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandra","family":"Lenz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierre","family":"Tennstedt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markus","family":"Graefen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefan","family":"Werner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Riethdorf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Derya","family":"Tilki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon A.","family":"Joosse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Pantel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,5,13]]},"reference":[{"issue":"6","key":"3397_CR1","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/nrclinonc.2014.68","volume":"11","author":"AJ Chang","year":"2014","unstructured":"Chang AJ, et al. High-risk prostate cancer-classification and therapy. Nat Rev Clin Oncol. 2014;11(6):308\u201323.","journal-title":"Nat Rev Clin Oncol"},{"issue":"12","key":"3397_CR2","doi-asserted-by":"publisher","first-page":"5574","DOI":"10.1002\/cam4.2474","volume":"8","author":"H Dillekas","year":"2019","unstructured":"Dillekas H, Rogers MS, Straume O. Are 90% of deaths from cancer caused by metastases? Cancer Med. 2019;8(12):5574\u20136.","journal-title":"Cancer Med"},{"issue":"4","key":"3397_CR3","doi-asserted-by":"publisher","first-page":"1063","DOI":"10.1093\/advances\/nmab135","volume":"13","author":"S Jin","year":"2022","unstructured":"Jin S, Je Y. Dairy consumption and total cancer and cancer-specific mortality: a meta-analysis of prospective cohort studies. Adv Nutr. 2022;13(4):1063\u201382.","journal-title":"Adv Nutr"},{"issue":"2","key":"3397_CR4","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.eururo.2023.04.021","volume":"84","author":"O Bergengren","year":"2023","unstructured":"Bergengren O, et al. 2022 update on prostate cancer epidemiology and risk factors-a systematic review. Eur Urol. 2023;84(2):191\u2013206.","journal-title":"Eur Urol"},{"issue":"3","key":"3397_CR5","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"5","key":"3397_CR6","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1053\/j.seminoncol.2018.01.003","volume":"44","author":"EM Sebesta","year":"2017","unstructured":"Sebesta EM, Anderson CB. The surgical management of prostate cancer. Semin Oncol. 2017;44(5):347\u201357.","journal-title":"Semin Oncol"},{"issue":"12","key":"3397_CR7","doi-asserted-by":"publisher","first-page":"3115","DOI":"10.3390\/biomedicines10123115","volume":"10","author":"AS Rzhevskiy","year":"2022","unstructured":"Rzhevskiy AS, et al. Liquid biopsy in diagnosis and prognosis of non-metastatic prostate cancer. Biomedicines. 2022;10(12):3115.","journal-title":"Biomedicines"},{"issue":"2","key":"3397_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.euo.2023.01.014","volume":"6","author":"F Mattana","year":"2023","unstructured":"Mattana F, et al. Metastatic sites\u2019 location and impact on patient management after the introduction of prostate-specific membrane antigen positron emission tomography in newly diagnosed and biochemically recurrent prostate cancer: a critical review. Eur Urol Oncol. 2023;6(2):128\u201336.","journal-title":"Eur Urol Oncol"},{"issue":"1","key":"3397_CR9","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1373\/clinchem.2018.287102","volume":"65","author":"K Pantel","year":"2019","unstructured":"Pantel K, Hille C, Scher HI. Circulating tumor cells in prostate cancer: from discovery to clinical utility. Clin Chem. 2019;65(1):87\u201399.","journal-title":"Clin Chem"},{"issue":"1","key":"3397_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.15252\/emmm.201303698","volume":"7","author":"SA Joosse","year":"2015","unstructured":"Joosse SA, Gorges TM, Pantel K. Biology, detection, and clinical implications of circulating tumor cells. EMBO Mol Med. 2015;7(1):1\u201311.","journal-title":"EMBO Mol Med"},{"issue":"1","key":"3397_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1007\/s10555-016-9611-7","volume":"35","author":"SA Joosse","year":"2016","unstructured":"Joosse SA, Pantel K. Genetic traits for hematogeneous tumor cell dissemination in cancer patients. Cancer Metastasis Rev. 2016;35(1):41\u20138.","journal-title":"Cancer Metastasis Rev"},{"issue":"1","key":"3397_CR12","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1158\/0008-5472.CAN-12-3422","volume":"73","author":"SA Joosse","year":"2013","unstructured":"Joosse SA, Pantel K. Biologic challenges in the detection of circulating tumor cells. Cancer Res. 2013;73(1):8\u201311.","journal-title":"Cancer Res"},{"issue":"5","key":"3397_CR13","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1038\/nrurol.2018.25","volume":"15","author":"C Hille","year":"2018","unstructured":"Hille C, Pantel K. Prostate cancer: circulating tumour cells in prostate cancer. Nat Rev Urol. 2018;15(5):265\u20136.","journal-title":"Nat Rev Urol"},{"issue":"1","key":"3397_CR14","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1373\/clinchem.2019.310912","volume":"66","author":"SA Joosse","year":"2020","unstructured":"Joosse SA, et al. Tumor-associated release of prostatic cells into the blood after transrectal ultrasound-guided biopsy in patients with histologically confirmed prostate cancer. Clin Chem. 2020;66(1):161\u20138.","journal-title":"Clin Chem"},{"issue":"1","key":"3397_CR15","doi-asserted-by":"publisher","first-page":"7196","DOI":"10.1038\/s41598-017-07649-z","volume":"7","author":"M Mohme","year":"2017","unstructured":"Mohme M, et al. Circulating tumour cell release after cement augmentation of vertebral metastases. Sci Rep. 2017;7(1):7196.","journal-title":"Sci Rep"},{"issue":"2","key":"3397_CR16","doi-asserted-by":"publisher","first-page":"442","DOI":"10.3390\/cancers12020442","volume":"12","author":"C Koch","year":"2020","unstructured":"Koch C, et al. Pre-analytical and analytical variables of label-independent enrichment and automated detection of circulating tumor cells in cancer patients. Cancers (Basel). 2020;12(2):442.","journal-title":"Cancers (Basel)"},{"issue":"4","key":"3397_CR17","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1158\/1078-0432.CCR-11-2100","volume":"18","author":"SA Joosse","year":"2012","unstructured":"Joosse SA, et al. Changes in keratin expression during metastatic progression of breast cancer: impact on the detection of circulating tumor cells. Clin Cancer Res. 2012;18(4):993\u20131003.","journal-title":"Clin Cancer Res"},{"issue":"34","key":"3397_CR18","doi-asserted-by":"publisher","first-page":"56066","DOI":"10.18632\/oncotarget.10701","volume":"8","author":"A Babayan","year":"2017","unstructured":"Babayan A, et al. Comparative study of whole genome amplification and next generation sequencing performance of single cancer cells. Oncotarget. 2017;8(34):56066\u201380.","journal-title":"Oncotarget"},{"issue":"1","key":"3397_CR19","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1186\/s13058-019-1184-2","volume":"21","author":"C Riebensahm","year":"2019","unstructured":"Riebensahm C, et al. Clonality of circulating tumor cells in breast cancer brain metastasis patients. Breast Cancer Res. 2019;21(1):101.","journal-title":"Breast Cancer Res"},{"key":"3397_CR20","unstructured":"Joosse SA. In-Silico Online v2.4.0. Accessed on 2024 Oct. Available from: http:\/\/in-silico.online."},{"issue":"1","key":"3397_CR21","doi-asserted-by":"publisher","first-page":"5680","DOI":"10.1038\/s41467-021-25917-5","volume":"12","author":"B Hamza","year":"2021","unstructured":"Hamza B, et al. Measuring kinetics and metastatic propensity of CTCs by blood exchange between mice. Nat Commun. 2021;12(1):5680.","journal-title":"Nat Commun"},{"issue":"3","key":"3397_CR22","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1002\/cyto.a.20369","volume":"71","author":"AG Tibbe","year":"2007","unstructured":"Tibbe AG, Miller MC, Terstappen LW. Statistical considerations for enumeration of circulating tumor cells. Cytometry A. 2007;71(3):154\u201362.","journal-title":"Cytometry A"},{"issue":"2","key":"3397_CR23","doi-asserted-by":"publisher","first-page":"300060523115209","DOI":"10.1177\/03000605231152091","volume":"51","author":"Y Wang","year":"2023","unstructured":"Wang Y, et al. The progress of dorsal vascular complex control strategy in radical prostatectomy. J Int Med Res. 2023;51(2):3000605231152091.","journal-title":"J Int Med Res"},{"issue":"6","key":"3397_CR24","doi-asserted-by":"publisher","first-page":"835","DOI":"10.3390\/cancers11060835","volume":"11","author":"M Janning","year":"2019","unstructured":"Janning M, et al. Determination of PD-L1 expression in circulating tumor cells of NSCLC patients and correlation with response to PD-1\/PD-L1 inhibitors. Cancers (Basel). 2019;11(6):835.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"3397_CR25","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1186\/s12894-023-01350-2","volume":"23","author":"T Bejrananda","year":"2023","unstructured":"Bejrananda T, Pliensiri P. Prediction of biochemical recurrence after laparoscopic radical prostatectomy. BMC Urol. 2023;23(1):183.","journal-title":"BMC Urol"},{"issue":"5","key":"3397_CR26","doi-asserted-by":"publisher","first-page":"645","DOI":"10.1038\/s41588-018-0078-z","volume":"50","author":"J Armenia","year":"2018","unstructured":"Armenia J, et al. The long tail of oncogenic drivers in prostate cancer. Nat Genet. 2018;50(5):645\u201351.","journal-title":"Nat Genet"},{"key":"3397_CR27","doi-asserted-by":"publisher","first-page":"baab043","DOI":"10.1093\/database\/baab043","volume":"2021","author":"Q Huang","year":"2021","unstructured":"Huang Q, et al. The progenetix oncogenomic resource in 2021. Database (Oxford). 2021;2021:baab043.","journal-title":"Database (Oxford)"},{"issue":"10","key":"3397_CR28","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1373\/clinchem.2018.289819","volume":"64","author":"SA Joosse","year":"2018","unstructured":"Joosse SA, et al. Chromosomal aberrations associated with sequential steps of the metastatic cascade in colorectal cancer patients. Clin Chem. 2018;64(10):1505\u201312.","journal-title":"Clin Chem"},{"issue":"11","key":"3397_CR29","doi-asserted-by":"publisher","first-page":"1656","DOI":"10.3390\/cancers11111656","volume":"11","author":"E Buscail","year":"2019","unstructured":"Buscail E, et al. High clinical value of liquid biopsy to detect circulating tumor cells and tumor exosomes in pancreatic ductal adenocarcinoma patients eligible for up-front surgery. Cancers (Basel). 2019;11(11):1656.","journal-title":"Cancers (Basel)"},{"issue":"10","key":"3397_CR30","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1038\/s41568-019-0180-2","volume":"19","author":"L Keller","year":"2019","unstructured":"Keller L, Pantel K. Unravelling tumour heterogeneity by single-cell profiling of circulating tumour cells. Nat Rev Cancer. 2019;19(10):553\u201367.","journal-title":"Nat Rev Cancer"},{"issue":"4","key":"3397_CR31","doi-asserted-by":"publisher","first-page":"670","DOI":"10.1016\/j.cell.2016.11.037","volume":"168","author":"AW Lambert","year":"2017","unstructured":"Lambert AW, Pattabiraman DR, Weinberg RA. Emerging biological principles of metastasis. Cell. 2017;168(4):670\u201391.","journal-title":"Cell"},{"issue":"2","key":"3397_CR32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1038\/s41580-018-0080-4","volume":"20","author":"A Dongre","year":"2019","unstructured":"Dongre A, Weinberg RA. New insights into the mechanisms of epithelial-mesenchymal transition and implications for cancer. Nat Rev Mol Cell Biol. 2019;20(2):69\u201384.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"17","key":"3397_CR33","doi-asserted-by":"publisher","first-page":"5112","DOI":"10.1158\/1078-0432.CCR-16-3081","volume":"23","author":"L Xu","year":"2017","unstructured":"Xu L, et al. The novel association of circulating tumor cells and circulating megakaryocytes with prostate cancer prognosis. Clin Cancer Res. 2017;23(17):5112\u201322.","journal-title":"Clin Cancer Res"},{"issue":"9","key":"3397_CR34","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1158\/1078-0432.CCR-23-3083","volume":"30","author":"H Cho","year":"2024","unstructured":"Cho H, et al. Impact of circulating tumor cell-expressed prostate-specific membrane antigen and prostate-specific antigen transcripts in different stages of prostate cancer. Clin Cancer Res. 2024;30(9):1788\u2013800.","journal-title":"Clin Cancer Res"},{"issue":"22","key":"3397_CR35","doi-asserted-by":"publisher","first-page":"4892","DOI":"10.1158\/0008-5472.CAN-20-1216","volume":"80","author":"JD Schonhoft","year":"2020","unstructured":"Schonhoft JD, et al. Morphology-predicted large-scale transition number in circulating tumor cells identifies a chromosomal instability biomarker associated with poor outcome in castration-resistant prostate cancer. Cancer Res. 2020;80(22):4892\u2013903.","journal-title":"Cancer Res"},{"key":"3397_CR36","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.semcancer.2021.02.001","volume":"78","author":"S Werner","year":"2022","unstructured":"Werner S, Heidrich I, Pantel K. Clinical management and biology of tumor dormancy in breast cancer. Semin Cancer Biol. 2022;78:49\u201362.","journal-title":"Semin Cancer Biol"},{"issue":"3","key":"3397_CR37","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1038\/s43018-021-00181-0","volume":"2","author":"M Esposito","year":"2021","unstructured":"Esposito M, Ganesan S, Kang Y. Emerging strategies for treating metastasis. Nat Cancer. 2021;2(3):258\u201370.","journal-title":"Nat Cancer"},{"issue":"1","key":"3397_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.devcel.2018.02.015","volume":"45","author":"G Follain","year":"2018","unstructured":"Follain G, et al. Hemodynamic forces tune the arrest, adhesion, and extravasation of circulating tumor cells. Dev Cell. 2018;45(1):33-52 e12.","journal-title":"Dev Cell"},{"issue":"3","key":"3397_CR39","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1038\/s41585-022-00677-z","volume":"20","author":"V Sailer","year":"2023","unstructured":"Sailer V, et al. Experimental in vitro, ex vivo and in vivo models in prostate cancer research. Nat Rev Urol. 2023;20(3):158\u201378.","journal-title":"Nat Rev Urol"},{"issue":"19","key":"3397_CR40","doi-asserted-by":"publisher","first-page":"10524","DOI":"10.3390\/ijms221910524","volume":"22","author":"N Banik","year":"2021","unstructured":"Banik N, et al. Heparin and its derivatives: challenges and advances in therapeutic biomolecules. Int J Mol Sci. 2021;22(19):10524.","journal-title":"Int J Mol Sci"},{"issue":"1","key":"3397_CR41","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1186\/s12943-018-0937-3","volume":"18","author":"G Sokeland","year":"2019","unstructured":"Sokeland G, Schumacher U. The functional role of integrins during intra- and extravasation within the metastatic cascade. Mol Cancer. 2019;18(1):12.","journal-title":"Mol Cancer"},{"issue":"9","key":"3397_CR42","doi-asserted-by":"publisher","first-page":"3942","DOI":"10.1039\/D0NA00271B","volume":"2","author":"N Ortiz-Otero","year":"2020","unstructured":"Ortiz-Otero N, et al. Platelet mediated TRAIL delivery for efficiently targeting circulating tumor cells. Nanoscale Adv. 2020;2(9):3942\u201353.","journal-title":"Nanoscale Adv"},{"issue":"1","key":"3397_CR43","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s10555-020-09942-2","volume":"40","author":"X Cheng","year":"2021","unstructured":"Cheng X, Cheng K. Visualizing cancer extravasation: from mechanistic studies to drug development. Cancer Metastasis Rev. 2021;40(1):71\u201388.","journal-title":"Cancer Metastasis Rev"}],"container-title":["Journal of Experimental &amp; Clinical Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13046-025-03397-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13046-025-03397-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,13]],"date-time":"2025-05-13T09:04:09Z","timestamp":1747127049000},"score":1,"resource":{"primary":{"URL":"https:\/\/jeccr.biomedcentral.com\/articles\/10.1186\/s13046-025-03397-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,5,13]]},"references-count":43,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3397"],"URL":"https:\/\/doi.org\/10.1186\/s13046-025-03397-5","relation":{},"ISSN":["1756-9966"],"issn-type":[{"value":"1756-9966","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,5,13]]},"assertion":[{"value":"12 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 May 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the local ethics committee (ethics review board Aerztekammer Hamburg), approval number PV5392. All recruited patients gave written consent to participate in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"143"}}